The World Drug Safety Congress Americas for over 10 years has served as the only commercially focused event for the pharmacovigilance community. In 2018, we were proud to be the only event to gather over 30 Global Heads of PV from the leading pharmaceutical companies including Merck, Novartis, Roche, Pfizer, Astellas, Boehringer Ingelheim, CSL Behring, Alnylam, Shire, Kite-Gilead, AstraZeneca, Moderna, Zogenix, Intarcia, GlaxoSmithKline, Quark, Portola, Celgene, Keyrus, Taimei, Fibrogen and Genzyme.
Due to overwhelming demand from the community we will be adding a predictive safety and medical device focus to the event. We will also include perspectives on global pharmacovigilance from stakeholders outside the U.S.
We know we had to turn away some great firms that wanted to showcase some fantastic solutions as we did not have enough space in 2018. If you reach out to us now we will be able to get you sorted for 2019 in the agenda or on the exhibition.
The 2019 event will also feature a new venue to accommodate the rapid growth we had this past year. Join over 500 of the leading stakeholders in the drug safety industry as we gather on April 15-17th at the Pennsylvania Convention Center.
If you are interested in sponsorship or speaking opportunities then contact Joseph Sica ASAP at firstname.lastname@example.org as we sold out in 2018 and are assigning them now for 2019.